Clinical Effectiveness and Safety of Vericiguat in Worsening Heart Failure with Reduced Ejection Fraction: A Single-center, Retrospective Analysis in Indian Patients

Background and Objective: In a tertiary care hospital in India, investigators evaluated the efficacy and safety of vericiguat, a new oral soluble guanylate cyclase stimulator in patients with worsening symptoms of heart failure and reduced ejection fraction (HFrEF). Methods: A retrospective assessme...

Descripció completa

Dades bibliogràfiques

Autors principals:	Pankaj Jariwala, Avvaru Guru Prakash, Poondru Rohith Reddy, Dilip Gude, Gururaj Pramod Kulkarni, Arshad Punjani, Harikishan Boorugu, Dilip Babu Madhawar, Anusha Jariwala
Format:	Artigo
Idioma:	Inglês
Publicat:	Wolters Kluwer Medknow Publications 2025-01-01
Col·lecció:	Journal of the Practice of Cardiovascular Sciences
Matèries:	cardiovascular mortality hospitalization for heart failure soluble guanylyl cyclase vericiguat worsening heart failure
Accés en línia:	https://journals.lww.com/10.4103/jpcs.jpcs_63_24
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!